These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1830013)

  • 1. Role of adrenal and gonadal androgens in insulin action and metabolism.
    Kitabchi AE; Buffington CK; Givens J; Inouye H
    Nihon Naibunpi Gakkai Zasshi; 1991 Mar; 67(3):203-13. PubMed ID: 1830013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females.
    Buffington CK; Givens JR; Kitabchi AE
    Diabetes; 1991 Jun; 40(6):693-700. PubMed ID: 1828239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced post-receptor insulin effects in women following dehydroepiandrosterone infusion.
    Schriock ED; Buffington CK; Givens JR; Buster JE
    J Soc Gynecol Investig; 1994; 1(1):74-8. PubMed ID: 9419751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovarian syndrome.
    Buffington CK; Kitabchi AE
    Metabolism; 1994 Nov; 43(11):1367-72. PubMed ID: 7968591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
    Falcone T; Finegood DT; Fantus IG; Morris D
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1653-7. PubMed ID: 2146285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
    Buyalos RP; Geffner ME; Azziz R; Judd HL
    Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of pyruvate dehydrogenase to insulin in activated T lymphocytes. Lack of responsiveness to insulin in patients with polycystic ovarian disease and diabetes.
    Buffington CK; Givens JR; Kitabchi AE
    Diabetes; 1990 Mar; 39(3):361-8. PubMed ID: 2407584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced adrenocortical activity as a contributing factor to diabetes in hyperandrogenic women.
    Buffington CK; Givens JR; Kitabchi AE
    Metabolism; 1994 May; 43(5):584-90. PubMed ID: 8177046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon in women with polycystic ovary syndrome (PCO): relationship to abnormalities of insulin and androgens.
    Golland IM; Vaughan Williams CA; Shalet SM; Laing I; Elstein M
    Clin Endocrinol (Oxf); 1990 Nov; 33(5):645-51. PubMed ID: 2147602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A; Kaufman JM; Giagulli VA
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
    Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.
    Robinson S; Kiddy D; Gelding SV; Willis D; Niththyananthan R; Bush A; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):351-5. PubMed ID: 8222298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome.
    Vrbíková J; Hill M; Dvoráková K; Stanická S; Vondra K; Stárka L
    Gynecol Obstet Invest; 2004; 58(1):36-41. PubMed ID: 15087595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Mitrakou A; Hennes MM; Platanissiotis D; Kaklas N; Spina J; Georgiadou E; Hoffmann RG; Kissebah AH; Raptis S
    Metabolism; 1995 Apr; 44(4):525-31. PubMed ID: 7723677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
    Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
    Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.
    Pasquali R; Casimirri F; Venturoli S; Paradisi R; Mattioli L; Capelli M; Melchionda N; Labò G
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):110-6. PubMed ID: 6137924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Vrbíková J; Hill M; Stárka L; Cibula D; Bendlová B; Vondra K; Sulcová J; Snajderová M
    Eur J Endocrinol; 2001 Jun; 144(6):619-28. PubMed ID: 11375796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.